Stay updated on Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.

Latest updates to the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page
- ChecktodayChange DetectedA site-wide NIH notice was added, stating that some content may use “Super Intelligence” instead of “Artificial Intelligence” during a terminology transition.SummaryDifference0.3%

- Check7 days agoChange DetectedThe site footer now displays revision v3.7.2 instead of v3.7.1.SummaryDifference0.0%

- Check14 days agoChange DetectedThe site footer now displays software revision v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check35 days agoChange DetectedUI copy in the footer/help area was adjusted from 'Find Contact Information' to 'Find contact information'. The revision tag was updated to 'Revision: v3.7.0' to reflect the new version.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision (v3.6.6) is recorded. The page now includes the Contacts/Locations and Study Status sections, reflecting updated recruitment and contact details for the study.SummaryDifference0.2%

- Check78 days agoChange DetectedThe record history now includes 'Revision: v3.6.5' and removes 'Revision: v3.6.4', updating the latest site revision shown on the page.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab Combo in Advanced NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Advanced NSCLC Clinical Trial page.